Comparing Buzzy Ⓡ and Pikluc Ⓡ for Pain Relief in Pediatric Intramuscular Injections: A Randomized Equivalence Trial.

Pain Manag NursApr 21, 2026 (epub)
Clinical ResearchPediatrics

Jefferson Wildes da Silva Moura, Mari Takashima, Sabrina de Souza et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized equivalence trial evaluated the effectiveness of Buzzy Ⓡ and Pikluc Ⓡ for pain relief during intramuscular injections in children aged 1-11 years. In children aged 1-3 years, all devices demonstrated equivalent pain relief, while in those aged 4-11 years, self-reported pain did not show equivalence. The study included 170 participants.

Key findings

  • In children aged 1-3 years, all device comparisons showed equivalence in pain relief.
  • For ages 4-11 years, self-reported pain did not show equivalence across devices.
  • Observer-reported assessments suggested equivalence for Pikluc Ⓡ vs. Buzzy Ⓡ 30 seconds in older children.

Why it matters

Understanding effective non-pharmacological pain relief methods is crucial for improving the experience of pediatric patients during procedures. This study provides insights into the use of two devices that can help reduce pain during intramuscular injections.

Source

Published in Pain Manag Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.